Labcorp Holdings Inc. (LON:0JSY)

Market Cap	17.61B +5.4%
Revenue (ttm)	10.24B +8.3%
Net Income	636.22M +96.4%
EPS	7.58 +98.4%
Shares Out	n/a
PE Ratio	27.68
Forward PE	16.80
Dividend	2.18 (0.77%)
Ex-Dividend Date	Nov 26, 2025

Volume	113
Average Volume	194
Open	294.51
Previous Close	287.86
Day's Range	284.21 - 294.51
52-Week Range	214.08 - 295.02
Beta	1.00
RSI	72.59
Earnings Date	Feb 17, 2026

About Labcorp Holdings

Labcorp Holdings Inc. provides laboratory services. It operates through two segments, Diagnostics Laboratories and Biopharma Laboratory Services. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid, PAP, hemoglobin A1C, prostate-specific antigens, sexually transmitted diseases, hepatitis C, vitamin D, microbiology cultures and procedures, and alcohol and other substance-abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target...

• Industry: Medical - Equipment & Services
• Sector: Healthcare
• Founded: 1995
• Employees: 70,000
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0JSY

Financial Performance

In 2024, Labcorp Holdings's revenue was $13.01 billion, an increase of 6.97% compared to the previous year's $12.16 billion. Earnings were $746.00 million, an increase of 78.47%.

Financial numbers in USD